Skip to main content
Complete Olympic Games coverage at your fingertips
Your inside track on the Olympic Games
Enjoy unlimited digital access
$1.99
per week for 24 weeks
Complete Olympic Games coverage at your fingertips
Your inside track onthe Olympics Games
$1.99
per week
for 24 weeks
// //

Else Nutrition Holdings Inc TSX Venture: BABY-X

Today's Change
Volume
Real-Time Last Update TSX Venture Last Sale

Today's Trading

Day Low 2.780
Day High 2.890
Open:2.800
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Else Nutrition Holdings Inc is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

No rating

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Latest Press Releases

Plant-Based Food Companies Spell Doom for Meat Industry
- PR Newswire - PRF - Thu Jul 29, 7:50AM CDT
PR Newswire - PRF - CMTX
Thu Jul 29, 7:50AM CDT
/PRNewswire/ -- As the meat industry falls out of favor with consumers, plant-based food choices are becoming more and more popular. World-famous billionaire investor and long-time cultured meat advocate that over half the global meat supply would be replaced by cultured/plant-based meat within the next decade. According to Mellon, the meat-produced origins of COVID-19 may act as a catalyst for change in the entire food industry. "We need to do something about our food supply. We need to make it cleaner; we need to make it less environmentally damaging; and we need to remove antibiotics and hormones from the food supply," Mellon said. Companies like (TSXV:VERY) (OTCQB:VRYYF),(NASDAQ:TTCF), (NASDAQ:SFM),(NASDAQ:BYND), and (TSXV:BABY) (OTCQX:BABYF) are delivering the kind of plant-based, natural solutions the market is demanding at just the right moment.
Else Launches Clinical Study with Children's Hospital Colorado and Denver School of Medicine to Validate Growth Benefits of Else's Plant-Based Nutrition
- GlobeNewswire - Thu Jul 29, 6:15AM CDT
GlobeNewswire - CMTX
Thu Jul 29, 6:15AM CDT
ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) ("Else" or the "Company") the plant-based baby, toddler and children nutrition company, announces the launch of a clinical study aimed at validating its toddler and kids products support growth benefits in healthy young children vs. cow-milk-based formula. The study will be led be Prof. David Fleischer, and Prof. Carina Venter from the Allergy and Immunology Center, Children's Hospital Colorado and University of Colorado Denver School of Medicine. Prof. David Fleischer, and Prof. Carina Venter are leading research in the field of food allergy prevention and working with children with food allergies.
Plant-Based Food Market Generates Over $7 Billion in Revenue During Pandemic
- PR Newswire - PRF - Tue Jul 27, 7:50AM CDT
PR Newswire - PRF - CMTX
Tue Jul 27, 7:50AM CDT
/PRNewswire/ -- Some industries might have crumbled during the pandemic, but others, like the plant-based industry, experienced massive growth thanks to the growing health consciousness among consumers. Last year, the US plant-based food market to reach , growing nearly twice as fast as the total US retail food market. The plant-based milk category took the lead at , accounting for 35% of the total plant-based food market, while plant-based meat brought in . Following this shift in consumer interest, companies such as (TSXV: BABY) (OTCQX:BABYF),(NASDAQ:OTLY),(NASDAQ:HAIN),(NYSE:TSN) and(NASDAQ:STKLare seeing an increased interest in their products and higher revenues.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 2.370 +19.41% increase
on 07/19/21
Period Open:2.980
Price movement based on the high, low and last over the given period.
3.200 -11.56% decrease
on 07/06/21
-0.150 (-5.03%) decrease
since 06/30/21
3-Month 1.840 +53.80% increase
on 05/11/21
Period Open:2.700
Price movement based on the high, low and last over the given period.
3.200 -11.56% decrease
on 07/06/21
+0.130 (+4.81%) increase
since 04/30/21
52-Week 1.380 +105.07% increase
on 08/06/20
Period Open:1.980
Price movement based on the high, low and last over the given period.
5.070 -44.18% decrease
on 11/30/20
+0.850 (+42.93%) increase
since 07/30/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies